Cortecs contract
Cortecs contract
CORTECS, the biotechnology group, yesterday signed a deal with the Spanish drug group, Ferrer, for the distribution of its osteoporosis treatment Macritonin in Latin America. The companies expect sales of around $20m (pounds 12.3m) for the drug in the region in the five years after registration.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies